BlackRock Advisors’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $183K | Sell |
86,123
-262,742
| -75% | -$558K | ﹤0.01% | 2697 |
|
|
2016
Q3 | $1.17M | Sell |
348,865
-25,883
| -7% | -$86.7K | ﹤0.01% | 1694 |
|
|
2016
Q2 | $1.18M | Buy |
374,748
+19,414
| +5% | +$61K | ﹤0.01% | 1657 |
|
|
2016
Q1 | $1.18M | Buy |
355,334
+87,759
| +33% | +$292K | ﹤0.01% | 1623 |
|
|
2015
Q4 | $947K | Sell |
267,575
-39,439
| -13% | -$140K | ﹤0.01% | 1711 |
|
|
2015
Q3 | $1.54M | Buy |
307,014
+13,966
| +5% | +$70.2K | ﹤0.01% | 1429 |
|
|
2015
Q2 | $1.88M | Sell |
293,048
-289,412
| -50% | -$1.86M | ﹤0.01% | 1268 |
|
|
2015
Q1 | $4.1M | Buy |
582,460
+57,649
| +11% | +$406K | ﹤0.01% | 991 |
|
|
2014
Q4 | $4.05M | Sell |
524,811
-31,994
| -6% | -$247K | ﹤0.01% | 1006 |
|
|
2014
Q3 | $4.16M | Buy |
556,805
+54,050
| +11% | +$404K | ﹤0.01% | 993 |
|
|
2014
Q2 | $4.87M | Buy |
502,755
+343,598
| +216% | +$3.33M | ﹤0.01% | 952 |
|
|
2014
Q1 | $1.32M | Sell |
159,157
-562,297
| -78% | -$4.67M | ﹤0.01% | 1339 |
|
|
2013
Q4 | $6.09M | Sell |
721,454
-556,227
| -44% | -$4.69M | 0.01% | 927 |
|
|
2013
Q3 | $10.2M | Buy |
1,277,681
+322,622
| +34% | +$2.57M | 0.01% | 772 |
|
|
2013
Q2 | $7.37M | Buy |
+955,059
| New | +$7.37M | 0.01% | 856 |
|